Agency Information Collection Activities: Proposed Collection; Comment Request; Generic Clearance for the Collection of Qualitative Feedback on Agency Service Delivery, 34682-34683 [2017-15318]
Download as PDF
mstockstill on DSK30JT082PROD with NOTICES
34682
Federal Register / Vol. 82, No. 142 / Wednesday, July 26, 2017 / Notices
recommendations from the PEAC on top
areas for FDA to consider for action.
FDA intends to make background
material available to the public no later
than 2 business days before the meeting.
If FDA is unable to post the background
material on its Web site prior to the
meeting, the background material will
be made publicly available at the
location of the advisory committee
meeting, and the background material
will be posted on FDA’s Web site after
the meeting. Background material is
available at https://www.fda.gov/
AdvisoryCommittees/Calendar/
default.htm. Scroll down to the
appropriate advisory committee meeting
link.
Procedure: Interested persons may
present data, information, or views,
orally or in writing, on issues pending
before the committee. Written
submissions may be made to the contact
person on or before September 20, 2017.
Oral presentations from the public will
be scheduled between approximately
3:40 p.m. to 4:10 p.m. on October 11,
2017, and approximately 9 a.m. to 9:30
a.m. and 2:30 p.m. to 3 p.m. on October
12, 2017. Those individuals interested
in making formal oral presentations
should notify the contact person and
submit a brief statement of the general
nature of the evidence or arguments
they wish to present, the names and
addresses of proposed participants, and
an indication of the approximate time
requested to make their presentation on
or before September 12, 2017. Time
allotted for each presentation may be
limited. If the number of registrants
requesting to speak is greater than can
be reasonably accommodated during the
scheduled open public hearing session,
FDA may conduct a lottery to determine
the speakers for the scheduled open
public hearing session. The contact
person will notify interested persons
regarding their request to speak by
September 13, 2017.
Persons attending FDA’s advisory
committee meetings are advised that the
Agency is not responsible for providing
access to electrical outlets.
FDA welcomes the attendance of the
public at its advisory committee
meetings and will make every effort to
accommodate persons with disabilities.
If you require accommodations due to a
disability, please contact AnnMarie
Williams at Annmarie.Williams@
fda.hhs.gov, or 301–796–5966 at least 7
days in advance of the meeting.
FDA is committed to the orderly
conduct of its advisory committee
meetings. Please visit our Web site at
https://www.fda.gov/Advisory
Committees/AboutAdvisoryCommittees/
ucm111462.htm for procedures on
VerDate Sep<11>2014
17:49 Jul 25, 2017
Jkt 241001
public conduct during advisory
committee meetings. Please be advised
that, for the round table portion of the
meeting, FDA will prepare a summary
of discussion instead of detailed
transcripts.
Notice of this meeting is given under
the Federal Advisory Committee Act (5
U.S.C. app. 2).
Dated: July 20, 2017.
Anna K. Abram,
Deputy Commiissioner for Policy, Planning,
Legislation, and Analysis.
[FR Doc. 2017–15657 Filed 7–25–17; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Advisory Committee on Training in
Primary Care Medicine and Dentistry
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
The Advisory Committee on
Training in Primary Care Medicine and
Dentistry (ACTPCMD) has scheduled a
meeting. This meeting will be open to
the public. Information about
ACTPCMD and the agenda for this
meeting can be found on the ACTPCMD
Web site at https://www.hrsa.gov/
advisorycommittees/bhpradvisory/
ACTPCMD.
SUMMARY:
August 16, 2017, 10:00 a.m.–2:30
p.m. ET.
ADDRESSES: This meeting will be held
by webinar and teleconference. The
address for the meeting is 5600 Fishers
Lane, Rockville, Maryland 20857.
• The webinar link: https://
hrsa.connectsolutions.com/actpcmd.
• The conference call-in number:
1–888–946–3804. Passcode: 3214611.
FOR FURTHER INFORMATION CONTACT:
Anyone requesting information
regarding ACTPCMD should contact
Kennita R. Carter, MD, Designated
Federal Officer (DFO), Division of
Medicine and Dentistry, Bureau of
Health Workforce, HRSA, in one of
three ways: (1) Send a request to the
following address: Kennita R. Carter,
MD, DFO, Division of Medicine and
Dentistry, HRSA, 5600 Fishers Lane,
15N–116, Rockville, Maryland 20857;
(2) call 301–945–3505; or (3) send an
email to KCarter@hrsa.gov.
SUPPLEMENTARY INFORMATION:
ACTPCMD provides advice and
recommendations to the Secretary of
DATES:
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
HHS (Secretary) on policy, program
development, and other matters of
significance concerning the activities
under section 747 of Title VII of the
Public Health Service (PHS) Act,
including dentistry activities.
ACTPCMD prepares an annual report
describing the activities of the
Committee, including findings and
recommendations made by the
Committee concerning the activities
under section 747, including dentistry
activities. The annual report is
submitted to the Secretary and ranking
members of the Senate Committee on
Health, Education, Labor and Pensions,
and the House of Representatives
Committee on Energy and Commerce.
The Committee also develops,
publishes, and implements performance
measures and guidelines for
longitudinal evaluations of programs
authorized under Title VII, Part C, of the
PHS Act, and recommends
appropriation levels for programs under
this Part.
During the August 16, 2017, meeting,
ACTPCMD will discuss issues related to
the Committee reports under
development. Agenda items are subject
to change as priorities dictate.
Members of the public will have the
opportunity to provide comments.
Public participants may submit written
statements in advance of the scheduled
meeting. Oral comments will be
honored in the order they are requested
and may be limited as time allows.
Requests to submit a written statement
or make oral comments to ACTPCMD
should be sent to Kennita R. Carter, MD,
DFO, using the contact information
above at least 3 business days prior to
the meeting.
Individuals who need special
assistance or another reasonable
accommodation should notify Dr.
Kennita R. Carter at the address and
phone number listed above at least 10
days prior to the meeting.
Amy McNulty,
Acting Director, Division of the Executive
Secretariat.
[FR Doc. 2017–15665 Filed 7–25–17; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency Information Collection
Activities: Proposed Collection;
Comment Request; Generic Clearance
for the Collection of Qualitative
Feedback on Agency Service Delivery
Department of Health and
Human Services (HHS).
AGENCY:
E:\FR\FM\26JYN1.SGM
26JYN1
Federal Register / Vol. 82, No. 142 / Wednesday, July 26, 2017 / Notices
30-Day notice of submission of
information collection approval from
the Office of Management and Budget
and request for comments.
ACTION:
As part of a Federal
Government-wide effort to streamline
the process to seek feedback from the
public on service delivery, U.S.
Department of Health and Human
Services has submitted a Generic
Information Collection Request (Generic
ICR): ‘‘Generic Clearance for the
Collection of Qualitative Feedback on
Agency Service Delivery’’ to OMB for
approval under the Paperwork
Reduction Act (PRA).
DATES: Comments on the ICR must be
received on or before August 25, 2017.
ADDRESSES: Submit your comments to
OIRA_submission@omb.eop.gov or via
facsimile to (202) 395–5806.
FOR FURTHER INFORMATION CONTACT:
Sherrette Funn, Report Clearance
Officer, at either Sherrette.Funn@
HHS.GOV or (202) 795–7714.
SUPPLEMENTARY INFORMATION:
Title: Generic Clearance for the
Collection of Qualitative Feedback on
Agency Service Delivery.
Abstract: The information collection
activity will garner qualitative customer
and stakeholder feedback in an efficient,
timely manner, in accordance with the
Administration’s commitment to
improving service delivery. By
qualitative feedback we mean
information that provides useful
insights on perceptions and opinions,
but are not statistical surveys that yield
quantitative results that can be
generalized to the population of study.
This feedback will provide insights into
customer or stakeholder perceptions,
experiences and expectations, provide
an early warning of issues with service,
or focus attention on areas where
communication, training or changes in
operations might improve delivery of
products or services. These collections
will allow for ongoing, collaborative and
actionable communications between the
Agency and its customers and
stakeholders. It will also allow feedback
to contribute directly to the
improvement of program management.
Feedback collected under this generic
clearance will provide useful
information, but it will not yield data
that can be generalized to the overall
population. This type of generic
clearance for qualitative information
will not be used for quantitative
information collections that are
designed to yield reliably actionable
results, such as monitoring trends over
time or documenting program
performance. Such data uses require
mstockstill on DSK30JT082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:49 Jul 25, 2017
Jkt 241001
more rigorous designs that address: The
target population to which
generalizations will be made, the
sampling frame, the sample design
(including stratification and clustering),
the precision requirements or power
calculations that justify the proposed
sample size, the expected response rate,
methods for assessing potential nonresponse bias, the protocols for data
collection, and any testing procedures
that were or will be undertaken prior
fielding the study. Depending on the
degree of influence the results are likely
to have, such collections may still be
eligible for submission for other generic
mechanisms that are designed to yield
quantitative results.
The Agency received no comments in
response to the 60-day notice published
in the May 8, 2017, issue of the Federal
Register (82 FR 21392–21393).
Current Actions: Extension of
approval for a collection of information.
Type of Review: Extension.
Affected Public: Individuals,
households, professionals, public/
private sector.
Average Expected Annual Number of
Activities: 40.
Respondents per Activity: 25,000.
Annual Responses: 1,000,000.
Frequency of Response: Once per
request.
Average minutes per response: 5.
Burden hours: 500,000 hours
annually.
An agency may not conduct or
sponsor, and a person is not required to
respond to, a collection of information
unless it displays a currently valid
Office of Management and Budget
control number.
Darius Taylor,
Deputy Information Collection Officer.
[FR Doc. 2017–15318 Filed 7–25–17; 8:45 am]
BILLING CODE 4150–05–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Center for Scientific
Review Special Emphasis Panel, August
01, 2017, 12:00 p.m. to August 02, 2017,
05:00 p.m., National Institutes of Health,
6701 Rockledge Drive, Bethesda, MD,
20892 which was published in the
Federal Register on July 12, 2017, 82 FR
32189.
The meeting will be held on August
1, 2017 and will start at 2:00 p.m. and
end at 5:00 p.m. The meeting location
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
34683
remains the same. The meeting is closed
to the public.
Dated: July 20, 2017.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–15614 Filed 7–25–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel NCI SPORE
Review.
Date: October 19–20, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Rockville, MD 20852.
Contact Person: Majed M. Hamawy, Ph.D.,
Scientific Review Officer, Special Review
Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W120, Bethesda, MD
20892–9750, 240–276–6457 mh101v@nih.gov
Name of Committee: National Cancer
Institute Special Emphasis Panel NCI
Program Project IV (P01) Review.
Date: October 26–27, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington/Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Klaus B Piontek, MD,
Ph.D., Scientific Review Officer, Special
Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W116,
Bethesda, MD 20892–9750, 240–276–5413
klaus.piontek@nih.gov
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
E:\FR\FM\26JYN1.SGM
26JYN1
Agencies
[Federal Register Volume 82, Number 142 (Wednesday, July 26, 2017)]
[Notices]
[Pages 34682-34683]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-15318]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency Information Collection Activities: Proposed Collection;
Comment Request; Generic Clearance for the Collection of Qualitative
Feedback on Agency Service Delivery
AGENCY: Department of Health and Human Services (HHS).
[[Page 34683]]
ACTION: 30-Day notice of submission of information collection approval
from the Office of Management and Budget and request for comments.
-----------------------------------------------------------------------
SUMMARY: As part of a Federal Government-wide effort to streamline the
process to seek feedback from the public on service delivery, U.S.
Department of Health and Human Services has submitted a Generic
Information Collection Request (Generic ICR): ``Generic Clearance for
the Collection of Qualitative Feedback on Agency Service Delivery'' to
OMB for approval under the Paperwork Reduction Act (PRA).
DATES: Comments on the ICR must be received on or before August 25,
2017.
ADDRESSES: Submit your comments to OIRA_submission@omb.eop.gov or via
facsimile to (202) 395-5806.
FOR FURTHER INFORMATION CONTACT: Sherrette Funn, Report Clearance
Officer, at either Sherrette.Funn@HHS.GOV or (202) 795-7714.
SUPPLEMENTARY INFORMATION:
Title: Generic Clearance for the Collection of Qualitative Feedback
on Agency Service Delivery.
Abstract: The information collection activity will garner
qualitative customer and stakeholder feedback in an efficient, timely
manner, in accordance with the Administration's commitment to improving
service delivery. By qualitative feedback we mean information that
provides useful insights on perceptions and opinions, but are not
statistical surveys that yield quantitative results that can be
generalized to the population of study. This feedback will provide
insights into customer or stakeholder perceptions, experiences and
expectations, provide an early warning of issues with service, or focus
attention on areas where communication, training or changes in
operations might improve delivery of products or services. These
collections will allow for ongoing, collaborative and actionable
communications between the Agency and its customers and stakeholders.
It will also allow feedback to contribute directly to the improvement
of program management.
Feedback collected under this generic clearance will provide useful
information, but it will not yield data that can be generalized to the
overall population. This type of generic clearance for qualitative
information will not be used for quantitative information collections
that are designed to yield reliably actionable results, such as
monitoring trends over time or documenting program performance. Such
data uses require more rigorous designs that address: The target
population to which generalizations will be made, the sampling frame,
the sample design (including stratification and clustering), the
precision requirements or power calculations that justify the proposed
sample size, the expected response rate, methods for assessing
potential non-response bias, the protocols for data collection, and any
testing procedures that were or will be undertaken prior fielding the
study. Depending on the degree of influence the results are likely to
have, such collections may still be eligible for submission for other
generic mechanisms that are designed to yield quantitative results.
The Agency received no comments in response to the 60-day notice
published in the May 8, 2017, issue of the Federal Register (82 FR
21392-21393).
Current Actions: Extension of approval for a collection of
information.
Type of Review: Extension.
Affected Public: Individuals, households, professionals, public/
private sector.
Average Expected Annual Number of Activities: 40.
Respondents per Activity: 25,000.
Annual Responses: 1,000,000.
Frequency of Response: Once per request.
Average minutes per response: 5.
Burden hours: 500,000 hours annually.
An agency may not conduct or sponsor, and a person is not required
to respond to, a collection of information unless it displays a
currently valid Office of Management and Budget control number.
Darius Taylor,
Deputy Information Collection Officer.
[FR Doc. 2017-15318 Filed 7-25-17; 8:45 am]
BILLING CODE 4150-05-P